Literature DB >> 32270312

Incidence and predictors of axillary web syndrome and its association with lymphedema in women following breast cancer treatment: a retrospective study.

Kathryn Ryans1,2, Claire C Davies3, Gizela Gaw4, Caroline Lambe5, Morgan Henninge6, Lisa VanHoose7.   

Abstract

PURPOSE: Axillary web syndrome (AWS) presents as a common postsurgical complication in individuals with breast cancer. Breast cancer-related lymphedema (BCRL) contributes to the shoulder and arm morbidity common in breast cancer survivors and often associated to cancer treatment. A paucity of literature exists evaluating the risk factors for developing AWS and the association between AWS and BCRL. The purposes of this study were (1) to identify risk factors for AWS in individuals with breast cancer, (2) to examine the association between BCRL and AWS, and (3) to determine if AWS increases the risk for developing BCRL.
METHODS: A retrospective study of 354 women who underwent breast cancer treatment and received physical therapy was included.
RESULTS: Axillary web syndrome developed in a third of women and predominately occurred in the first 8 postoperative weeks. The odds of AWS development were 73% greater for participants over the age of 60 (OR = 1.73, CI 95% 1.05-2.84). Women with AWS had 44% greater risk to develop lymphedema during the first postoperative year (RR = 1.44, CI 95% 1.12-1.84, p = 0.002). If AWS developed within the first postoperative month, women were almost 3 times more likely to develop lymphedema within the first 3 postoperative months compared with other women with AWS (RR = 2.75, CI 95% 1.199-6.310, p = 0.007).
CONCLUSIONS: Our findings suggest that 30% of breast cancer survivors will have AWS during the first year of survivorship. As institutions prioritize screening efforts, early postoperative prospective surveillance is needed for women over 60 due to high risk for AWS development and any women with AWS for increased risk of lymphedema development based on our findings.

Entities:  

Keywords:  Axillary web syndrome; Breast cancer–related lymphedema; Cording; Incidence; Predictors

Mesh:

Year:  2020        PMID: 32270312     DOI: 10.1007/s00520-020-05424-x

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  3 in total

1.  Five-Year Cumulative Incidence of Axillary Web Syndrome and Comparison in Upper Extremity Movement, Function, Pain, and Lymphedema in Survivors of Breast Cancer With and Without Axillary Web Syndrome.

Authors:  Linda Koehler; Amanda Day; David Hunter; Anne Blaes; Tufia Haddad; Ryan Shanley
Journal:  Arch Phys Med Rehabil       Date:  2022-04-06       Impact factor: 4.060

2.  Randomised clinical trial of a manual therapy programme to reduce the evolution time of axillary web syndrome in women affected by breast cancer: study protocol.

Authors:  Jesús Baltasar González Rubino; Maria Jesus Vinolo-Gil; Cristina García Muñoz; Rocío Martín-Valero
Journal:  BMJ Open       Date:  2022-09-21       Impact factor: 3.006

Review 3.  Extracorporeal Shock Wave Therapy Combined with Complex Decongestive Therapy in Patients with Breast Cancer-Related Lymphedema: A Systemic Review and Meta-Analysis.

Authors:  Yu Lin Tsai; Ting Jie I; Ya Chi Chuang; Yuan Yang Cheng; Yu Chun Lee
Journal:  J Clin Med       Date:  2021-12-19       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.